findmyKOL

Satyam Sarma, MD

Basic profile

Texas Health Dallas

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH funding2019–2022Why? →

Satyam Sarma is a Cardiology physician affiliated with Texas Health Dallas. OpenAlex indexes 249 publications with 4,622 citations (h-index 32).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
249publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,622citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 2019–2022

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5323 Harry Hines Blvd
Dallas, TX 753907201

Telephone

214-645-8000

Registry record last updated 30 Jul 2013.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    73.4%
    Beta blocker21.5%
    Metoprolol Succinate52%Carvedilol33%Metoprolol Tartrate15%
    Part D<11 patients
    Statin19.5%
    Atorvastatin Calcium71%Rosuvastatin Calcium29%
    Part D27 patients

    + 7 more classes in this area

  • Blood & clotting

    20.8%
    Factor Xa inhibitor11.6%
    Eliquis62%Xarelto38%
    Part D<11 patients
    P2Y12 inhibitor4.6%
    Clopidogrel100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    2%
    SGLT2 inhibitor2%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)78.5% facility · 21.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20192022 per NIH RePORTER. The latest:

1 more award record behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”